Investors are advised to stay calm amid volatility, focus on defensive stocks like HUL and NTPC, and watch for explosive ...

The MM-II trial was carried out in partnership with Israel-based Moebius Medical and included 397 patients in the US, Europe, ...

Discover the Sun Pharma Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

Sun Pharmaceutical Industries Ltd. closed 8.84% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

MARKS & Spencer is working with spooks to find out whether foreign criminals were behind a cyber attack that has caused ...

Tariff worries continue hanging over companies as they report their latest financial results and try to provide guidance on ...

Reality TV is fun, but this felt like, ‘Oh, my gosh. This is it,'' the 'Hills' alum says of entering the world of daytime ...

Sun Pharmaceutical Industries Ltd. closed 7.94% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Private equity activity in healthcare remained resilient with 42 deals worth $562 million, just shy of last quarter’s $603 ...

If 340B is eliminated or weakened, large pharmaceutical companies will benefit at the expense of health care access across ...

Medical device maker Intuitive Surgical said on Tuesday that U.S. tariffs will increasingly weigh on its business for the rest of the year, disrupting operations in China and potentially eroding its ...

Systematix Group's Vishal Manchanda anticipates Q4 results for pharma companies to align with previous quarters, with high ...